Organization
Charite-Universitaetsmedizin Berlin
2 abstracts
Abstract
Lacutamab in patients with relapsed and/or refractory mycosis fungoides: Results from the TELLOMAK phase 2 trial.Org: Hôpital Saint Louis, Multidisciplinary Cutaneous Lymphoma Program, Rochester Skin Lymphoma Medical Group, CHU de Rouen - Hôpital Charles-Nicolle, Universitair Ziekenhuis Leuven,
Abstract
ENGOT-EN20/GOG-3083/xport-EC-042: A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma.Org: University Hospitals Leuven, Leuven, Belgium, Leuven Cancer Institute, BGOG, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark, Copenhagen University Hospital,